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Abstract
Background: Measurement of health-related quality of life (HRQoL) in dementia is difficult. At some point people
with dementia become unable to meaningfully assess their own HRQoL. At such a point in time researchers need
to rely on other types of information such as observation or assessments from informal caregivers (proxies).
However, caregiver assessments may be biased by several mechanisms. The current study explores whether
caregivers project part of their own HRQoL in their assessments of patient HRQoL.
Methods: The participants in the current study were 175 pairs, consisting of community-dwelling persons with
dementia and their caregivers. The EQ-5D, the EQ-VAS and the QoL-AD were administered to collect HRQoL
measurements from patients and caregivers at baseline, 6 months and 12 months. Two linear mixed models were
used to investigate factors that bias proxy ratings, one with the EQ-VAS as dependent variable, and one with the
EQ-5D utility as dependent variable. The independent variables were caregiver age, caregiver sex and caregiver
QoL-AD items.
Results: The linear mixed model with EQ-VAS as dependent variable indicated that 3 caregiver characteristics,
namely caregiver age, money (caregiver’s financial situation) and valuation of life as a whole were significant
predictors of the patient-by-proxy VAS scores. The linear mixed model with utility value as the dependent variable
showed that caregiver age and valuation of the ability to do things for fun were significant predictors of the
patient-by-proxy EQ-5D utility values.
Conclusions: The current study was a first step in identifying factors that bias patient-by-proxy HRQoL assessments.
It was discovered that caregivers project part of their own HRQoL onto patients when assessing patient HRQoL.
This implies that patient-by-proxy HRQoL values should be interpreted with caution and not be used as a direct
substitute for patient self-assessment, even when patients are no longer able meaningfully assess themselves.
Background
Dementia describes a class of neurologic illnesses that
cause progressive decline in cognitive functioning. Areas
that are affected most severely are memory, reasoning,
communication skills and the ability to carry out daily ac-
tivities. In addition, people with dementia frequently suffer
from behavioural and noncognitive symptoms such as de-
pression, wandering, aggression, agitation, sleep distur-
bances, shouting, repeated questioning and psychosis [1].
Dementia is posing a great threat for the future of
current health care expenditures as future scenarios
claim that dementia prevalence may have doubled or tri-
pled by 2050 [2,3]. With an increase in the number of
patients with dementia, many governments will have to
change their policies and focus on keeping patients out
of nursing homes as long as possible. This is only pos-
sible with adequate pharmacological and psycho-social
interventions. The evaluations of such programs should
incorporate outcome measures such as health-related
quality of life (HRQoL). Ideally, these HRQoL measures
should be valid, reliable, and precise.
However, measurement of HRQoL in dementia is not
without difficulties. First and foremost, the concept lacks
a generally accepted definition. Several reviews have
been published that describe the number and applicabil-
ity of HRQoL instruments in dementia [4-7]. They show
that more than a dozen dementia-specific instruments
are available, each covering different domains and apply-
ing different methods of measurement.
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Many researchers and clinicians argue that HRQoL is
subjective in nature and thus only patient ratings should
be considered valid. However, the very problem in demen-
tia is that patients’ cognitive functioning decreases and
therefore their ratings might become less valid or even un-
usable. Therefore, reliable and valid informal caregiver
(proxy) ratings could be extremely useful in the field of de-
mentia. Yet, using proxy ratings might have disadvantages.
Numerous studies report on agreement and differ-
ences between the dementia patients’ HRQoL ratings
and those of patient-by-proxy [8-11]. They show a sys-
tematic underreporting of patient HRQoL by caregivers,
as compared to patient self-assessment. These findings
are in line with proxy reporting from other disease areas
[12-19]. These studies identified factors that improved
agreement between patients and caregivers. Such factors
were higher patient education [20], a family caregiver
(vs. other), lower levels of patient functional disability,
higher levels of patient depression and lower caregiver
burden [19], the type of perspective employed and
higher patient cognitive functioning [13].
Dementia is a disease that not only affects patients
but also their caregivers. Surprisingly, not much re-
search has been done to identify caregiver characteris-
tics that could influence agreement between patients
and caregivers. Other than the type of caregiver, the per-
spective used [13], and caregiver burden [21], no care-
giver characteristics have been identified. It has been
acknowledged that providing care often results in per-
sonal, psychological, social and financial losses [22-26],
although there are also care giving uplifts such as feel-
ings of satisfaction, personal growth, enhancement and
enrichment [27,28]. One could imagine that changes in
these domains might have an influence on patient-
by-proxy HRQoL ratings.
One study showed that caregiver HRQoL is related to
the type of dementia and the coping style of the caregiver
[29]. In addition, providing care for a patient with demen-
tia is associated with a decline in HRQoL in both mental
and physical domains [30]. Furthermore, it is unclear
whether caregivers ‘project’ part of their own HRQoL
problems onto patient HRQoL. For example, caregivers
might underestimate the HRQoL of patients if they experi-
ence a diminished HRQoL themselves. This mechanism of
caregiver ‘projection’ has been investigated in stroke [31]
and other contexts such as end-of-life decisions [32,33]. In
the latter context it is acknowledged that caregivers are
imperfect decision makers and projection of caregivers’
preferences guide their decisions. If such a mechanism is
present in patient-by-proxy HRQoL ratings then this is a
type of bias of which clinicians and policy makers should
be aware. The aim of this explorative study is to assess
whether certain caregiver characteristics contribute to a
bias of patient-by-proxy HRQoL assessments.
Methods
Respondents
The participants in the current study were dyads, con-
sisting of community-dwelling persons with dementia and
their informal caregivers, drawn from the AD-Euro RCT
(a cost-effectiveness study on regular post-diagnosis care
in dementia by memory clinics versus by general practi-
tioners) [34,35]. The current study includes patients with
a newly diagnosed dementia fulfilling DSM-IV-TR criteria
and a score of 0.5-2 on the Clinical Dementia Rating
(CDR; 0–3) scale: 0 for none; 0.5 for questionable/very
mild; 1 for mild; 2 for moderate; and 3 for severe dementia
[1,36]. In addition to the CDR, the Mini-Mental State
Examination (MMSE) was administered, although scores
on this instrument were not an inclusion or exclusion cri-
terion [37]. Verbal and written consent of both the patient
and caregiver were obtained when they were considered
eligible at a screening in a multidisciplinary memory clinic.
Patients were excluded if data collection was impossible
(for example because of a severe hearing or language im-
pairment), if they had a short life expectancy, if they were
awaiting nursing home admission, or in case of a definite
indication for specific memory clinic follow-up (for ex-
ample having been diagnosed with a rare dementia). Data
was collected by trained interviewers who administered
the questionnaires and the response tasks at the patients’
homes. The instrument protocols were followed providing
a standardized interview format across respondents. To
maximize privacy and reduce potential bias, the person
with dementia and the caregiver were interviewed separ-
ately. Interviews were conducted at a mutually convenient
time. Measurements were obtained at baseline (T = 0),
6 months (T = 6) and 12 months (T = 12).
Conceptual framework
Three perspectives to assess HRQoL were used, two of
those were partially based on the work of Pickard and
Knight [38]. First of all there is the patient self assessment
(patient-patient perspective) of HRQoL. Second there is
the assessment by the proxy of the patient’s HRQoL
(patient-by-proxy perspective). In the current study care-
givers were asked to rate patients from their own perspec-
tive. Pickard and Knight discuss one more perspective
where proxies are asked to assess the patient as they think
the patient would respond. This perspective was not used
in the current study. Additionally, the caregiver’s own
HRQoL was assessed (caregiver self-assessment).
(Health-related) quality of life measures
QoL-AD
The QoL-AD is a dementia-specific quality of life (QOL)
instrument [39,40]. It has 13 items covering the domains
of physical health, energy, mood, living situation, memory,
family, marriage, friends, self as a whole, chores, fun,
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money (financial situation), and life as a whole. Items are
scored on a 4 point rating-scale ranging from 1 (poor) to 4
(excellent). There are separate versions available for pa-
tients and caregivers, and there is a version available for
the caregiver’s own QOL [41]. The questions asked were:
“How would you value your own (specific domains are
mentioned here)?” for patient and caregiver self-
assessments and “How would you value the person you
care for his/her (specific domains)?” for patient-by-proxy
assessments.
EQ-5D
The EQ-5D is a generic HRQoL instrument in which re-
spondents evaluate their health state “today”. The classifi-
cation system consists of five domains: mobility, self-care,
usual activities, pain/discomfort and anxiety/depression,
with three levels of severity per domain [42]. These levels
indicate “no problems”, “some problems” or “severe prob-
lems”. The EQ-5D is the one of the most widely used
index instruments, which is why it was chosen for this
study. To calculate the values for the EQ-5D the well
known UK tariff was used as described by Dolan [43]. The
instrument also includes a vertical visual analogue scale
(VAS) with a range of 0 (worst imaginable health state) to
100 (best imaginable health state). The EQ-5D was used
for patient self-assessment, patient-by-proxy assessment
and caregiver self-assessment.
Analyses
Descriptive statistics of complete dyad data at T = 0, T = 6
and T = 12 were used to analyze patient-patient, patient-
by-proxy and caregiver self-assessed HRQoL values. To
compare outcomes on a 0–100 scale, EQ-5D utility scores
were multiplied by 100 and QoL-AD sum scores (range
13–52) were transformed by applying the following for-
mula:
Scoretransformed ¼ sum score‐13ð Þ  2:564:
Intra-class correlation coefficients (ICC) were cal-
culated to assess the level of substitutability between
patient-patient and patient-by-proxy VAS and utility
values. The strength of agreement between patients and
caregivers is expressed as slight (ICC = 0.00-0.20), fair
(ICC = 0.21-0.40), moderate (ICC = 0.41-0.60), substantial
(ICC = 0.61-0.80) and almost perfect (ICC = 0.81-1.00).
The relationship of patient-by-proxy and caregiver
self-assessed HRQoL values was investigated by looking
at Pearson product–moment correlations coefficients (r)
between their EQ-VAS scores. The EQ-VAS was selected
for this analysis because this measure allows for the
most subjective assessments, improving the ability to de-
tect any biases. A significant correlation between the
EQ-VAS scores would be interpreted as a potential
projection bias in proxy assessments on patients. A simi-
lar analysis was performed on the EQ-5D utility values
to investigate whether projection is also present in
somewhat more objective assessments.
To investigate potential predictors of projection bias
of proxy HRQoL onto patient HRQoL, a linear mixed
model was used. Patient-by-proxy EQ-VAS was entered
as a dependent variable, while for predictor variables
caregiver age, sex, and caregiver self-assessed QoL-AD
items were entered. These variables were used in the
model at T = 0, T = 6 and T = 12. Age and sex were in-
cluded in the model because these are very common
confounders. In addition, the QoL-AD items were in-
cluded to investigate which caregiver characteristics
could bias patient-by-proxy assessments. The analysis
was restricted to only these predictors because sufficient
power to detect significant predictors needed to be pre-
served [44]. Here too a similar analysis was performed
on the EQ-5D utility values. The dependent variable was
the patient-by-proxy EQ-5D utility value, while caregiver
age, sex and the caregiver self-assessed QoL-AD items
were independent variables.
Results
Respondents
In total, 175 patients were included in the study, their
descriptive statistics are provided below (Table 1). The
sample consisted mostly of older patients with mild to
moderate dementia. Most patients had a family care-
giver, either a spouse or a child.
HRQoL outcomes
Caregiver self-assessed HRQoL assessments were the
highest, followed by patient-patient and patient-by-proxy
HRQoL assessments (Figure 1) on all three instruments
at each time of measurement. EQ-5D values were the
highest ( x caregiver self-assessed = 88.59, x patient-
patient = 82.77, x patient-by-proxy = 67.12), followed by
VAS values (x caregiver self-assessed = 78.84, x patient-
patient = 72.78 x patient-by-proxy = 65.33), followed by
the QoL-AD values ( x caregiver self-assessed = 63.86,
x patient-patient = 59.65 x patient-by-proxy = 45.05).
Patient-proxy substitutability
The ICC of patient-patient and patient-by-proxy VAS
values were 0.18 at T = 0, 0.22 at T = 6 and 0.42 at T = 12.
The ICC of patient-patient and patient-by-proxy utility
values were 0.50 at T = 0, 0.46 at T = 6 and 0.51 at T = 12.
Projection bias
There were significant correlations between the patient-
by-proxy and caregiver self-assessed VAS scores on each
of the three times of measurement. The correlations
were 0.25 at T = 0 (p = 0.001), 0.43 at T = 6 (p < 0.001)
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and 0.20 at T = 12 (p = 0.012), thus indicating weak to
moderate correlations. The correlations between the
patient-by-proxy and caregiver self-assessed utility
values were non-significant at each time of measure-
ment (T = 0: r = 0.11, p > 0.1, T = 6: r = 0.13 p > 0.1, and
T = 12: r = 0.12, p > 0.1).
The linear mixed model indicated that 3 caregiver
characteristics, namely caregiver age, money (caregiver’s
financial situation) and valuation of life as a whole were
significant predictors of the patient-by-proxy VAS scores
(Table 2). This model had a combined 498 observations
across the three measurement times. A total of 407
observations were used in the model. The linear mixed
model with utility value as the dependent variable
showed that caregiver age and valuation of the ability to
do things for fun were significant predictors of the
patient-by-proxy EQ-5D utility scores (Table 3). This
model had a combined 525 observations across the three
measurement times. A total of 486 observations were
used in the model.
Discussion
The current study attempted to explore the existence of
potentially biasing factors that might influence patient-
Table 1 Descriptive statistics of patient and caregiver dyads at T = 0, T = 6 and T = 12 months
T = 0 (n = 175) T = 6 (n = 151) T = 12 (n = 144)
n (%) Mean (SD) n (%) Mean (SD) n (%) Mean (SD)
Patient
Age 78.6 (5.7) 78.5 (5.8) 78.4 (5.7)
Female 106 (60.6%) 90 (59.6%) 88 (38.9%)
Type of dementia
Alzheimer 105 (60%) 93 (61.6%) 89 (61.8%)
Vascular 15 (8.6%) 9 (6.0%) 7 (4.9%)
Mixed 49 (28.0%) 43 (28.5%) 43 (29.9%)
Other 6 (3.4%) 6 (4.0%) 5 (3.5%)
CDR
0.5 8 (4.6%) 8 (5.3%) 6 (4.2%)
1 139 (19.4%) 120 (79.5%) 117 (81.3%)
2 28 (16.0%) 23 (15.2%) 21 (14.6%)
Caregiver
Age 64.0 (13.2) 64.1 (13.2) 64.3 (13.2)
Female 123 (70.3%) 106 (70.2%) 101 (70.1%)
Relation to patient
Spouse 94 (53.7%) 83 (55%) 80 (55.6%)
Child 72 (41.1%) 59 (39.1%) 55 (38.2%)
Other 9 (5.1%) 9 (6.0%) 9 (6.3%)
Figure 1 EQ-5D values, EQ-VAS scores and QoL-AD sum scores (patient, caregiver, and patient-by-proxy) at baseline, 6 months and
12 months. EQ-5D and QoL-AD values were rescaled between 0–100.
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by-proxy HRQoL assessments in dementia. A significant
correlation between patient-by-proxy and caregiver self-
assessed EQ-VAS scores was found. This correlation
remained statistically significant over time. Moreover,
characteristics of caregivers were identified that bias
their VAS ratings on patients.
A biasing factor on VAS ratings that was identified
was ‘life as a whole’. This factor has at face value a great
contribution to projection. Caregivers incorporate part
of their overall assessments of their own lives into the
assessments of the patients’ lives. Should this finding be
replicated then such a bias can be overcome by
Table 2 Proxy characteristics as predictors of patient-by-proxy VAS scores in a linear mixed model
β-Coefficient p-value 95% confidence interval
Intercept 51.26 0.000 25.48 - 77.05
Proxy sex 0.45 0.852 −4.34 - 5.25
Proxy age 0.19 0.033 0.02 - 0.36
Physical health −0.32 0.846 −3.59 - 2.94
Energy 1.70 0.294 −1.49 - 4.90
Mood 0.22 0.901 −3.30 - 3.74
Living situation −0.82 0.611 −3.97 - 2.34
Memory −2.28 0.271 −6.35 - 1.79
Family −1.04 0.524 −4.24 - 2.17
Marriage 1.09 0.498 −2.08 - 4.26
Friends 1.15 0.493 −2.14 - 4.44
Self as a whole −0.96 0.645 −5.08 - 3.16
Ability to do chores around the house 0.96 0.520 −1.98 - 3.91
Ability to do things for fun 0.84 0.539 −1.85 - 3.52
Money −5.53 0.005 −9.37 - −1.70
Life as a whole 5.78 0.004 1.84 - 9.71
R2 = 0.068 (R2 compared to an intercept only model).
Table 3 Proxy characteristics as predictors of patient-by-proxy EQ-5D utility values in a linear mixed model
β-Coefficient p-value 95% confidence interval
Intercept 0.07 0.734 −0.04 - 0.53
Proxy sex −0.01 0.760 −0.10 - 0.07
Proxy age 0.01 0.000 0.00 - 0.01
Physical health 0.04 0.154 −0.02 - 0.10
Energy 0.04 0.159 0.02 - 0.10
Mood −0.05 0.128 −0.11 - 0.01
Living situation 0.02 0.507 −0.04 - 0.07
Memory −0.04 0.304 −0.11 - 0.03
Family 0.01 0.834 −0.05 - 0.06
Marriage 0.01 0.632 −0.04 - 0.07
Friends 0.00 0.926 −0.06 - 0.07
Self as a whole 0.01 0.733 −0.06 - 0.08
Ability to do chores around the house −0.02 0.526 −0.07 - 0.04
Ability to do things for fun 0.05 0.041 0.00 - 0.10
Money −0.03 0.417 −0.09 - 0.04
Life as a whole 0.03 0.417 −0.04 - 0.01
R2 = 0.095 (R2 compared to an intercept only model).
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measuring caregiver HRQoL alongside patients. Re-
searchers might then adjust the ratings of caregivers on
patients by using a correction algorithm.
Another biasing factor on VAS ratings that was identi-
fied was ‘money’. This factor contributes strongly to the
overall rating. As this estimate was negative this implies
that the better the caregivers’ financial situation are, the
worse their ratings on patient HRQoL will be and vice
versa. This is a new finding and to the authors’ knowledge
has not been previously reported elsewhere. These results
seem counterintuitive, as previous research has demon-
strated that having more or enough money would improve
(HR)QoL [45]. A possible explanation for this relationship
could be that financial status functions as a mediating
variable for socio-economic status (SES). Caregivers with a
higher SES might perceive the impact dementia has on the
patient and themselves to be bigger than lower SES prox-
ies. This might indicate that caregivers with higher SES
perceive more shame and experience the difference in
HRQoL between themselves and the patient to be larger.
More research is needed to further explore this finding.
The least strong characteristic was caregiver age. Age
contributed little to the overall rating, but older care-
givers gave higher ratings. This finding is in line with
general findings that aspects of QOL such as happiness
are rated higher as age increases [46,47]. Moreover, be-
cause spousal caregivers are generally older than child
caregivers, it is highly likely that spousal caregivers rate
patients higher than child caregivers do. If such is the
case, then this might have serious implications for out-
comes research. For example, if a new study is to be initi-
ated to evaluate a new intervention which uses spousal
caregivers to assess the HRQoL of people with dementia,
such a study might overestimate the effects on HRQoL
when compared to a study that solely uses child care-
givers. Further research is required to corroborate this
finding. It is acknowledged that age is one of the most
common confounders in observational research. Never-
theless, clinicians and policy makers should be made
aware of its potentially biasing effects on HRQoL ratings.
There were two biasing factors on utility values, care-
giver age and ‘ability to do things for fun’. The implica-
tions for caregiver age are similar to the VAS ratings
that were discussed previously. Interestingly, the ability
of caregivers to do things for fun biases their assess-
ments of the EQ-5D items on patients. Since the
β-coefficient is positive this means that caregivers who
are better able to do things for fun give better ratings of
patient functioning. One possible explanation for this
phenomenon might be that caregivers who undertake
many fun activities with a patient also think that the pa-
tient experiences a similar level of fun. It might thus be
possible that the amount of fun caregivers experience
bias their assessment of patient functioning.
These newly identified factors differ from those previ-
ously identified in other research areas. For example,
patient depression has previously been identified as a
factor leading to an increase in patient and proxy differ-
ences for elderly patients visiting the emergency room
[38]. In addition, burden and psychological distress in
caregivers was a significant predictor of patient and
proxy differences in psychosocial scores in veterans [48].
A different study [49] that focused more on functional
status through (instrumental) activities of daily living
identified the following factors that contribute to more
disagreement between patients and proxies: female prox-
ies, proxies who lived with the patient, proxies who were
not first-order relatives of the patient, and proxies who
assisted patients with (instrumental) activities of daily
living. The newly identified factors thus provide fruitful
grounds for new research on systematic differences be-
tween patient and proxy assessments.
It should be noted that the explained variance of both
linear mixed models was low. However, with the current
study design, this is a desirable outcome. If the models
would explain all of the variance then this would imply
that patient-by-proxy assessments would only be based on
proxy characteristics and not on patient characteristics. In
this study the explained variance in the models was less
than 10% which suggests that the bias that is present in
patient-by-proxy HRQoL assessments is small compared
to the influence of actual patient characteristics.
In general, measurement of HRQoL in dementia is dif-
ficult. In other disease areas patient self-assessment is
usually regarded as a gold standard against which proxy
assessment is compared. HRQoL is a very subjective
concept and thus patients have ‘privileged access’. In de-
mentia however, researchers have questioned the as-
sumption that people with dementia should be regarded
as the gold standard since cognitive impairments might
lead to less valid self-assessments. For example, Lawton
[50] noted “most cognitively impaired patients do not
introspect, or at least do not report reliably on interior
phenomena”. However, the authors feel that patients’
self-assessment is the best measure of HRQoL, as long
as the patients can deliver this measure [51]. If patients
cannot give their HRQoL assessment anymore, one has
to rely on proxy measures. However, since cognitive
functions are primarily affected by dementia, caregivers
may be less capable of assessing the internal state of the
dementia patients they care for and therefore they might
provide less valid HRQoL assessments compared to
other disease areas.
Patient-by-proxy assessments can be used for two dis-
tinct purposes. The first is substitution of patient self-
assessment. In this situation the patient self-assessment is
considered a gold standard to compare patient-by-proxy as-
sessment with. However, when patient-by-proxy assessments
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are used in addition to patient self-assessment, for ex-
ample to provide extra information for clinical decision
making, then patient-self-assessment should not be con-
sidered a gold standard. In this context, proxy reporting
might even be more valid than patient-self assessment as
the disease progresses. Nevertheless, the biases that were
identified might occur in both substitution judgments and
informing clinical decision making.
One major limitation of the current study is that the
proxy perspective investigating how HRQoL is according
to the patient was not measured. We therefore cannot
conclude whether or not caregivers actually know how
patients would assess themselves. The addition of this
perspective could provide additional information on
caregiver bias, since it might be different when multiple
perspectives are used [52]. In addition, the relatively
short follow up time and the relatively homogenous
sample make it difficult to generalize the current find-
ings to a broader context.
Conclusion
Proxy assessment is an important aspect of the evalu-
ation of people with dementia, yet a bias is present.
Many caregivers might report on different aspects than
patients, and thus the patient self-assessment and
patient-by-proxy assessment perspectives might be com-
plementary instead of being regarded interchangeable.
However, this makes it more difficult to deal with the
proxy bias that is present as shown in this study. Proxy
bias might have serious implications for clinical and pol-
icy decisions. Dementia is a progressive disease, in which
patients at some point become unable to express their
HRQoL in a meaningful and valid way. Therefore, after
such a point in time, one has to consider alternatives
such as proxies or behavioural observations. Nonethe-
less, if the bias found in this study is generalizable to
broader contexts, clinicians and policy makers should be
made aware of its influence on proxy HRQoL assess-
ments. For future studies we recommend measurement
of HRQoL of patients and proxies, with identical instru-
ments, and multiple perspectives. Should future studies
discover more complete causal models of reported
HRQoL values, it might then be possible to constrain
proxy biases to a minimum.
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